- Home
- LFVN vs TENX Comparison
LFVN vs TENX Comparison
Compare LFVN & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LFVN | TENX |
|---|---|---|
| Founded | N/A | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.5M | 56.2M |
| IPO Year | 1996 | 2001 |
Fundamental Metrics
Financial Performance| Metric | LFVN | TENX |
|---|---|---|
| Price | $4.14 | $14.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $11.00 | ★ $29.67 |
| AVG Volume (30 Days) | 77.7K | ★ 422.9K |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | ★ 4.32% | N/A |
| EPS Growth | ★ 226.09 | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $203,204,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $21.95 | ★ N/A |
| Revenue Growth | ★ 1.86 | N/A |
| 52 Week Low | $3.90 | $4.64 |
| 52 Week High | $15.00 | $18.38 |
Technical Indicators
Market Signals| Indicator | LFVN | TENX |
|---|---|---|
| Relative Strength Index (RSI) | 37.94 | 53.22 |
| Support Level | $3.99 | $12.71 |
| Resistance Level | $5.37 | $16.61 |
| Average True Range (ATR) | 0.21 | 1.12 |
| MACD | 0.01 | -0.10 |
| Stochastic Oscillator | 41.67 | 40.27 |
Price Performance
Historical ComparisonAbout LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.